Company receives multimillion dollar grant to focus on post-stroke recovery; Proven technology in 700 patients granted Breakthrough Device designation from the FDA EFFINGHAM, Ill.--(BUSINESS ...
Gamma‐aminobutyric acid (GABA) is the principal inhibitory neurotransmitter in the central nervous system, and its precise regulation is critical for maintaining neural circuit balance. GABA ...
HOUSTON. Amgen, the largest biotechnology company in the world, is funding research focusing on disorders that destroy parts of the nervous system. These include Alzheimer's disease, Parkinson's ...
The Forum on Neuroscience and Nervous System Disorders hosted a public workshop on September 8, 2017 that brought together key experts from academia, government, the biotechnology and pharmaceutical ...
The National Academies of Sciences, Engineering, and Medicine are private, nonprofit institutions that provide expert advice on some of the most pressing challenges facing the nation and world. Our ...
Synaptic plasticity—the brain's ability to modify the connections between neurons to support learning—is one of the neural functions profoundly altered in Huntington's disease, with a direct impact on ...
Multimodal therapy approaches (i.e., combinations of interventions aimed at different aspects of a disease) are emerging as potential ways to enhance clinical outcomes for patients with psychiatric ...
A new study published in Neurology, led by Queen Mary University of London, has revealed that people of South Asian, African and European ancestry share many of the same genetic risk factors for ...
Peroxisomes, since their discovery by Rhodin and De Duve, have been recognized as essential organelles involved in a myriad of biochemical processes vital for maintaining cellular homeostasis.
PhaseWell Research ("PhaseWell"), a multisite clinical research company, today announced the strategic acquisition of Chase ...
Foods rich in magnesium, omega-3s, probiotics, antioxidants, and more can help your nervous system function properly, ...